IP Library Granted Patent US 8,715,957
Granted Patent B2
US 8,715,957 · App. 13/191,375 · Granted May 6, 2014

Microorganisms and methods for the biosynthesis of aromatics, 2,4-pentadienoate and 1,3-butadiene

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,715,957
App. No.
13/191,375
Granted
May 6, 2014
Kind
B2
Abstract

The invention provides non-naturally occurring microbial organisms having a toluene, benzene, p-toluate, terephthalate, (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate, (2-hydroxy-4-oxobutoxy)phosphonate, benzoate, styrene, 2,4-pentadienoate, 3-butene-1ol or 1,3-butadiene pathway. The invention additionally provides methods of using such organisms to produce toluene, benzene, p-toluate, terephthalate, (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate, (2-hydroxy-4-oxobutoxy)phosphonate, benzoate, styrene, 2,4-pentadienoate, 3-butene-1ol or 1,3-butadiene.

Claims (10)

1. A non-naturally occurring microbial organism having a 1,3-butadiene pathway, wherein said microbial organism comprises the following set of said 1,3-butadiene pathway enzymes (i) acrylyl-CoA acetyltransferase, (ii) 3-oxopent-4-enoyl-CoA reductase, (iii) 3-hydroxypent-4-enoyl-CoA transferase, synthetase or hydrolase, and (iv) 3-hydroxypent-4-enoate decarboxylase, and wherein said microbial organism comprises at least one exogenous nucleic acid encoding an enzyme from said 1,3-butadiene pathway enzymes (i)-(iv) wherein said enzyme is expressed in a sufficient amount to produce 1,3-butadiene.

2. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises two, three, or four exogenous nucleic acids each encoding a 1,3-butadiene pathway enzyme.

3. The non-naturally occurring microbial organism of claim 1 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid.

4. The non-naturally occurring microbial organism of claim 1 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium.

5. The non-naturally occurring microbial organism of claim 1 , wherein said non-naturally occurring microbial organism is a species of bacteria, yeast or fungus.

6. A method for producing 1,3-butadiene, comprising culturing a non-naturally occurring microbial organism according to claim 1 , under conditions and for a sufficient period of time to produce 1,3-butadiene.

7. The method of claim 6 , wherein said microbial organism comprises two, three, or four exogenous nucleic acids each encoding a 1,3-butadiene pathway enzyme.

8. The method of claim 6 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid.

9. The method of claim 6 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium.

10. The method of claim 6 , wherein said non-naturally occurring microbial organism is a species of bacteria, yeast or fungus.

Assignments (4)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2011
From: OSTERHOUT, ROBIN E.; BURGARD, ANTHONY P.; PHARKYA, PRITI; BURK, MARK J.
To: GENOMATICA, INC.
Reel/Frame 026767/0346 →